A mouse model of chronic cerebral hypoperfusion characterizing features of vascular cognitive impairment

Methods in Molecular Biology

Volumn 1135, Issue , 2014, Pages 95-102

  Ihara, Masafumi ^a   Taguchi, Akihiko ^b   Maki, Takakuni ^c   Washida, Kazuo ^d   Tomimoto, Hidekazu ^e  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bilateral common carotid artery occlusion; Cerebral blood flow; Chronic cerebral hypoperfusion; Dementia; Laser speckle flowmetry; Microcoil; Mouse; Vascular cognitive impairment

Indexed keywords

ALZHEIMER DISEASE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BRAIN PERFUSION; C57BL 6 MOUSE; CAROTID ARTERY BIFURCATION; CELL THERAPY; CHRONIC CEREBRAL HYPOPERFUSION; COGNITIVE DEFECT; COMMON CAROTID ARTERY; DEMENTIA; MALE; MORTALITY; MOUSE; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; WHITE MATTER; CLINICAL FEATURE; MOLECULAR MECHANICS; MOUSE MODEL;

ANIMALS; CEREBRAL CORTEX; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE; MICE, INBRED C57BL; MIDDLE CEREBRAL ARTERY;

EID: 84896094150     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-320-7_8     Document Type: Article

References (26)

1. Ihara M, Tomimoto H, Ishizu K et al (2004) Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study. Stroke 35:942-947
2. Yao H, Sadoshima S, Kuwabara Y et al (1990) Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type. Stroke 21:1694-1699
3. Wakita H, Tomimoto H, Akiguchi I et al (1994) Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol 87:484-492
4. Shibata M, Ohtani R, Ihara M et al (2004) White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35:2598-2603
5. Kudo T, Tada K, Takeda M et al (1990) Learning impairment and microtubuleassociated protein 2 decrease in gerbils under chronic cerebral hypoperfusion. Stroke 21: 1205-1209
6. Sarti C, Pantoni L, Bartolini L et al (2002) Persistent impairment of gait performances and working memory after bilateral common carotid artery occlusion in the adult Wistar rat. Behav Brain Res 136:13-20
7. Ihara M, Tomimoto H (2011) Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes. J Aging Res 2011:978761
8. Shibata M, Yamasaki N, Miyakawa T et al (2007) Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 38:2826-2832
9. Coltman R, Spain A, Tsenkina Y et al (2011) Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging 32:2324.e7-12
10. Yoshizaki K, Adachi K, Kataoka S et al (2008) Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice. Exp Neurol 210:585-591
11. Stroke Therapy Academic Industry Roundtable (STAIR) (1999) Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30: 2752-2758
12. Farkas E, Luiten PG, Bari F (2007) Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusionrelated neurodegenerative diseases. Brain Res Rev 54:162-180
13. Jiwa NS, Garrard P, Hainsworth AH (2010) Experimental models of vascular dementia and vascular cognitive impairment: a systematic review. J Neurochem 115:814-828
14. Ni JW, Matsumoto K, Li HB et al (1995) Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res 673:290-296
15. Holland PR, Bastin ME, Jansen MA et al (2011) MRI is a sensitive marker of subtle white matter pathology in hypoperfused mice. Neurobiol Aging 32:2325.e1-6
16. Nishio K, Ihara M, Yamasaki N et al (2010) A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke 41:1278-1284
17. Maki T, Ihara M, Fujita Y et al (2011) Angiogenic and vasoprotective effects of adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in mice. Stroke 42:1122-1128
18. Maki T, Ihara M, Fujita Y et al (2011) Angiogenic roles of adrenomedullin through vascular endothelial growth factor induction. Neuroreport 22:442-447
19. Fujita Y, Ihara M, Ushiki T et al (2010) Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow. Stroke 41:2938-2943
20. Kalaria RN, Akinyemi R, Ihara M (2012) Does vascular pathology contribute to Alzheimer changes? J Neurol Sci 322(1-2):141-147
21. Okamoto Y, Yamamoto T, Kalaria RN et al (2012) Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol 123:381-394
22. Yamada M, Ihara M, Okamoto Y et al (2011) The influence of chronic cerebral hypoperfusion on cognitive function and amyloid β metabolism in APP overexpressing mice. PloS One 6:e16567
23. Nakaji K, Ihara M, Takahashi C et al (2006) Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke 37:2816-2823
24. Duan W, Gui L, Zhou Z et al (2009) Adenosine A2A receptor deficiency exacerbates white matter lesions and cognitive deficits induced by chronic cerebral hypoperfusion in mice. J Neurol Sci 285:39-45
25. Miki K, Ishibashi S, Sun L et al (2009) Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice. J Neurosci Res 87:1270-1281
26. Washida K, Ihara M, Nishio K et al (2010) Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptorgamma activation in mice with chronic cerebral hypoperfusion. Stroke 41:1798-1806